FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Guest Kevin
2. Issuer Name and Ticker or Trading Symbol

USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
C.E.O.
(Last)          (First)          (Middle)

3838 WEST PARKWAY BLVD
3. Date of Earliest Transaction (MM/DD/YYYY)

2/7/2022
(Street)

SALT LAKE CITY, UT 84120
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 2/8/2022  M  7004 A (1)13723 D  
Common Stock 2/8/2022  F  2967 D$94.30 10756 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units  (1)2/7/2022  A   26406     (3) (3)Common Stock 26406 $0 66034 D  
Restricted Stock Units  (1)2/8/2022  M     7004   (2) (2)Common Stock 7004 $0 59030 D  

Explanation of Responses:
(1) Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
(2) Restricted Stock Units vest 25% on the anniversary of February 8th, 2021.
(3) On February 7th, 2022, the reporting person was granted restricted stock units, vesting at 25% on each 7th of February thereafter.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Guest Kevin
3838 WEST PARKWAY BLVD
SALT LAKE CITY, UT 84120


C.E.O.

Signatures
Joshua Foukas, as attorney in fact2/10/2022
**Signature of Reporting PersonDate

USANA Health Sciences (NYSE:USNA)
Historical Stock Chart
Von Feb 2024 bis Mär 2024 Click Here for more USANA Health Sciences Charts.
USANA Health Sciences (NYSE:USNA)
Historical Stock Chart
Von Mär 2023 bis Mär 2024 Click Here for more USANA Health Sciences Charts.